Thermo Fisher TMO Featured in Europe Cell Therapy Sector Report
Thermo Fisher Scientific ($TMO) features prominently in a new industry analysis covering the European automated and closed cell therapy processing systems market through 2033. Published on Tuesday, September 22, 2026, the report highlights a structural transition toward decentralized manufacturing and modular CAR-T/ATMP workflows.
If European biopharma capital expenditure accelerates toward decentralized -T production, watch Thermo Fisher Scientific ($TMO+WL) for infrastructure demand across automated closed-system workflows.